D-0206-2026 Class II Ongoing

Recalled by Blossom Pharmaceuticals — Bardej, Goa

FDA drug recall D-0206-2026 was initiated by Blossom Pharmaceuticals on Oct 31, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 912 containers.

Recall details

Product Type
Drugs
Report Date
Dec 10, 2025
Initiation Date
Oct 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
912 containers

Product description

Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz (425g), Made in India, Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, NDC 75834-170-15.

Reason for recall

cGMP deviations

Distribution pattern

USA Nationwide

Code information

Lot #: A352318

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0206-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0206-2026. Report a data issue: hello@regdatalab.com.